Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity

ABSTRACT Background Maternal obesity (MO) impairs fetal skeletal muscle development, but the underlying mechanisms remain poorly defined. The regulatory roles of lncRNA H19 and its first exon derived microRNA675 (miR675) in prenatal muscle development remain to be examined. H19/Igf2 are in the same...

Full description

Saved in:
Bibliographic Details
Main Authors: Yao Gao, Md Nazmul Hossain, Liang Zhao, Xiangdong Liu, Yanting Chen, Jeanene Marie Deavila, Mei‐Jun Zhu, Gordon K. Murdoch, Min Du
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Online Access:https://doi.org/10.1002/jcsm.13791
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850119446097559552
author Yao Gao
Md Nazmul Hossain
Liang Zhao
Xiangdong Liu
Yanting Chen
Jeanene Marie Deavila
Mei‐Jun Zhu
Gordon K. Murdoch
Min Du
author_facet Yao Gao
Md Nazmul Hossain
Liang Zhao
Xiangdong Liu
Yanting Chen
Jeanene Marie Deavila
Mei‐Jun Zhu
Gordon K. Murdoch
Min Du
author_sort Yao Gao
collection DOAJ
description ABSTRACT Background Maternal obesity (MO) impairs fetal skeletal muscle development, but the underlying mechanisms remain poorly defined. The regulatory roles of lncRNA H19 and its first exon derived microRNA675 (miR675) in prenatal muscle development remain to be examined. H19/Igf2 are in the same imprinting cluster with H19 expressed from the maternal allele while Igf2 expresses paternally. H19 contains a G‐rich loop, and KH‐type splicing regulatory protein (KHSRP) mediates the biogenesis of pre‐miRNAs containing G‐rich loops, which depends on its phosphorylation by AKT, a key mediator of IGF2 signalling. This study aims to depict the elusive function of these regulators that are affected by MO during embryonic myogenesis. Methods Single‐cell transcriptomic sequencing and GeoMx spatial RNA sequencing were performed to identify the differentially expressed genes between embryos from MO and control (CT) mice. Both E11.5 and E13.5 embryos were collected and analysed to validate the sequencing data. The roles of H19 and miR657 in myogenesis were further analysed in P19 embryonic cells via CRISPR/dCas9‐mediated H19 activation and inhibition. The epigenetic changes of H19 were analysed by methylated DNA immunoprecipitation, and allele‐targeted analysis of H19 was performed by crossing C57BL/6J and CAST/EiJ mice. Results Transcriptomic analysis showed that MO embryos contained less differentiated myocytes (1.34%) than CT embryos (2.86%). Myogenesis‐related GO biological processes were down‐regulated in the MO embryonic myotome region. MO embryos showed lower expression of myogenic transcription factors such as Myf5, Myod1, Myog, Mef2c and Myh3 (p < 0.05). MO altered epigenetic modifications of the H19 genomic cluster, showing a decreased methylation level in H19 imprinting control region (p < 0.05) and a diallelic expression pattern of H19, which elevated its expression in MO embryos. Overexpression of H19 inhibited myogenesis in P19 cells, but miR675 promoted myogenesis, suggesting the critical regulatory roles of bioconversion of H19 to miR675. A KHSRP mediates the biogenesis of miR675, a process that relies on its phosphorylation by IGF2/AKT signalling. Knocking‐down of KHSRP and inhibition of AKT abolished miR675 biogenesis. MO suppressed IGF2/AKT signalling and blocked KHSRP‐dependent miR675 biogenesis in embryos. Conclusions We found differential effects of H19 and miR675 on embryonic myogenesis. MO up‐regulates H19 but blocks its miR675 bioconversion via suppressing IGF2/AKT/KHSRP signalling axis. Myogenesis in MO embryos was impeded due to the highly accumulated H19 and blocked miR675 biogenesis.
format Article
id doaj-art-e9f9df5f0a4f4d9f917c3ba299344d24
institution OA Journals
issn 2190-5991
2190-6009
language English
publishDate 2025-04-01
publisher Wiley
record_format Article
series Journal of Cachexia, Sarcopenia and Muscle
spelling doaj-art-e9f9df5f0a4f4d9f917c3ba299344d242025-08-20T02:35:37ZengWileyJournal of Cachexia, Sarcopenia and Muscle2190-59912190-60092025-04-01162n/an/a10.1002/jcsm.13791Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal ObesityYao Gao0Md Nazmul Hossain1Liang Zhao2Xiangdong Liu3Yanting Chen4Jeanene Marie Deavila5Mei‐Jun Zhu6Gordon K. Murdoch7Min Du8Nutrigenomics and Growth Biology Laboratory, Department of Animal Sciences Washington State University Pullman Washington USANutrigenomics and Growth Biology Laboratory, Department of Animal Sciences Washington State University Pullman Washington USACollege of Animal Science and Technology Nanjing Agricultural University Nanjing Jiangsu ChinaDana‐Farber Cancer Institute Boston Massachusetts USACollege of Animal Science and Technology Nanjing Agricultural University Nanjing Jiangsu ChinaNutrigenomics and Growth Biology Laboratory, Department of Animal Sciences Washington State University Pullman Washington USASchool of Food Science Washington State University Pullman Washington USANutrigenomics and Growth Biology Laboratory, Department of Animal Sciences Washington State University Pullman Washington USANutrigenomics and Growth Biology Laboratory, Department of Animal Sciences Washington State University Pullman Washington USAABSTRACT Background Maternal obesity (MO) impairs fetal skeletal muscle development, but the underlying mechanisms remain poorly defined. The regulatory roles of lncRNA H19 and its first exon derived microRNA675 (miR675) in prenatal muscle development remain to be examined. H19/Igf2 are in the same imprinting cluster with H19 expressed from the maternal allele while Igf2 expresses paternally. H19 contains a G‐rich loop, and KH‐type splicing regulatory protein (KHSRP) mediates the biogenesis of pre‐miRNAs containing G‐rich loops, which depends on its phosphorylation by AKT, a key mediator of IGF2 signalling. This study aims to depict the elusive function of these regulators that are affected by MO during embryonic myogenesis. Methods Single‐cell transcriptomic sequencing and GeoMx spatial RNA sequencing were performed to identify the differentially expressed genes between embryos from MO and control (CT) mice. Both E11.5 and E13.5 embryos were collected and analysed to validate the sequencing data. The roles of H19 and miR657 in myogenesis were further analysed in P19 embryonic cells via CRISPR/dCas9‐mediated H19 activation and inhibition. The epigenetic changes of H19 were analysed by methylated DNA immunoprecipitation, and allele‐targeted analysis of H19 was performed by crossing C57BL/6J and CAST/EiJ mice. Results Transcriptomic analysis showed that MO embryos contained less differentiated myocytes (1.34%) than CT embryos (2.86%). Myogenesis‐related GO biological processes were down‐regulated in the MO embryonic myotome region. MO embryos showed lower expression of myogenic transcription factors such as Myf5, Myod1, Myog, Mef2c and Myh3 (p < 0.05). MO altered epigenetic modifications of the H19 genomic cluster, showing a decreased methylation level in H19 imprinting control region (p < 0.05) and a diallelic expression pattern of H19, which elevated its expression in MO embryos. Overexpression of H19 inhibited myogenesis in P19 cells, but miR675 promoted myogenesis, suggesting the critical regulatory roles of bioconversion of H19 to miR675. A KHSRP mediates the biogenesis of miR675, a process that relies on its phosphorylation by IGF2/AKT signalling. Knocking‐down of KHSRP and inhibition of AKT abolished miR675 biogenesis. MO suppressed IGF2/AKT signalling and blocked KHSRP‐dependent miR675 biogenesis in embryos. Conclusions We found differential effects of H19 and miR675 on embryonic myogenesis. MO up‐regulates H19 but blocks its miR675 bioconversion via suppressing IGF2/AKT/KHSRP signalling axis. Myogenesis in MO embryos was impeded due to the highly accumulated H19 and blocked miR675 biogenesis.https://doi.org/10.1002/jcsm.13791embryonic myogenesisH19KHSRPmaternal obesitymiR675
spellingShingle Yao Gao
Md Nazmul Hossain
Liang Zhao
Xiangdong Liu
Yanting Chen
Jeanene Marie Deavila
Mei‐Jun Zhu
Gordon K. Murdoch
Min Du
Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity
Journal of Cachexia, Sarcopenia and Muscle
embryonic myogenesis
H19
KHSRP
maternal obesity
miR675
title Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity
title_full Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity
title_fullStr Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity
title_full_unstemmed Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity
title_short Balancing LncRNA H19 and miR‐675 Bioconversion as a Key Regulator of Embryonic Myogenesis Under Maternal Obesity
title_sort balancing lncrna h19 and mir 675 bioconversion as a key regulator of embryonic myogenesis under maternal obesity
topic embryonic myogenesis
H19
KHSRP
maternal obesity
miR675
url https://doi.org/10.1002/jcsm.13791
work_keys_str_mv AT yaogao balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT mdnazmulhossain balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT liangzhao balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT xiangdongliu balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT yantingchen balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT jeanenemariedeavila balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT meijunzhu balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT gordonkmurdoch balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity
AT mindu balancinglncrnah19andmir675bioconversionasakeyregulatorofembryonicmyogenesisundermaternalobesity